BioSpace News Archive

Drug Development

Clinical Catch-up from Last Week: May 28-31

Although the weekend was filled with news out of the American Society of Clinical Oncology Annual Meeting, here’s a roundup of some of the top clinical trial news from earlier last week.

May 31, 2019
·
8 min read
·
Mark Terry
Deals

Adaptive Biotech Plans $230 Million IPO to Advance Immune Sequencing Technologies

Founded in 2009 by brothers Chad and Harlan Robins, the company utilizes high-throughput gene sequencing with computer infrastructure that allows scientists to minutely analyze T-cell receptors.

May 31, 2019
·
2 min read
·
Mark Terry
Genetown

Adding Blood Pressure Drug to Pancreatic Cancer Treatment Could Simplify Tumor Removal

The new aspect of the procedure and the study is the addition of losartan, a drug for high blood pressure that is marketed as a generic form and under the brand name of Cozaar.

May 31, 2019
·
3 min read
·
Mark Terry
Business

Merrimack to Lay Off Remaining Execs and Staff, Sell Assets

Merrimack said the company will preserve its cash runway in order to provide time for additional milestone payments from Ipsen.

May 31, 2019
·
2 min read
·
Alex Keown
FDA

FDA Action Alert: Merck and Xeris

Here’s a look at what’s on the U.S. Food and Drug Administration’s calendar for the next two weeks.

May 31, 2019
·
2 min read
·
Mark Terry
ASLAN Pharma Takes on Full License of Atopic Dermatitis Drug in $775 Million-Plus Deal

The compound is a fully human monoclonal antibody targeting the IL-13 receptor alpha1 subunit and is being developed for atopic dermatitis and other inflammatory diseases.

May 31, 2019
·
2 min read
·
Mark Terry
Business

Beam Therapeutics and Japan’s Bio Palette Strike Base Editing Cross-Collaboration Agreement

Both companies said they plan to work together in order to strengthen their competitive positions.

May 31, 2019
·
2 min read
·
Alex Keown
BioForest

2019 BioSpace Life Sciences Ideal Employer Survey

Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.

May 31, 2019
·
1 min read
·
BioSpace Staff
Policy

Chinese Company Slows Down Investment in U.S. Biotech Sector Due to Trade Issues

Last year, China invested $2.8 billion in U.S. health care companies, a big jump from the $702.9 million in 2017.

May 31, 2019
·
3 min read
·
Alex Keown
Deals

Orthocell announces successful capital raising

Regenerative medicine company Orthocell Limited is pleased to announce that it has received firm commitments for a A$10.6m placement (“Placement”) from professional and sophisticated investors, including existing shareholders providing $10m net of expenses.

May 31, 2019
·
2 min read